Su, Chen-Yang
Zhou, Sirui
Gonzalez-Kozlova, Edgar
Butler-Laporte, Guillaume
Brunet-Ratnasingham, Elsa
Nakanishi, Tomoko
Jeon, Wonseok
Morrison, David R.
Laurent, Laetitia
Afilalo, Jonathan
Afilalo, Marc
Henry, Danielle
Chen, Yiheng
Carrasco-Zanini, Julia
Farjoun, Yossi
Pietzner, Maik
Kimchi, Nofar
Afrasiabi, Zaman
Rezk, Nardin
Bouab, Meriem
Petitjean, Louis
Guzman, Charlotte
Xue, Xiaoqing
Tselios, Chris
Vulesevic, Branka
Adeleye, Olumide
Abdullah, Tala
Almamlouk, Noor
Moussa, Yara
DeLuca, Chantal
Duggan, Naomi
Schurr, Erwin
Brassard, Nathalie
Durand, Madeleine
Del Valle, Diane Marie
Thompson, Ryan
Cedillo, Mario A.
Schadt, Eric
Nie, Kai
Simons, Nicole W.
Mouskas, Konstantinos
Zaki, Nicolas
Patel, Manishkumar
Xie, Hui
Harris, Jocelyn
Marvin, Robert
Cheng, Esther
Tuballes, Kevin
Argueta, Kimberly
Scott, Ieisha
,
Greenwood, Celia M. T.
Paterson, Clare
Hinterberg, Michael A.
Langenberg, Claudia
Forgetta, Vincenzo
Pineau, Joelle
Mooser, Vincent
Marron, Thomas
Beckmann, Noam D.
Kim-schulze, Seunghee
Charney, Alexander W.
Gnjatic, Sacha
Kaufmann, Daniel E.
Merad, Miriam
Richards, J. Brent
Funding for this research was provided by:
Canadian Institutes of Health Research (365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825, 365825)
Article History
Received: 2 June 2022
Accepted: 17 March 2023
First Online: 17 April 2023
Competing interests
: J.B.R. has served as an advisor to GlaxoSmithKline and Deerfield Capital and is the Founder of 5 Prime Sciences. The Lady Davis Institute has previously received funding from GlaxoSmithKline, Eli Lilly, and Biogen for research programs at Dr. Richards’ laboratory unrelated to this manuscript. C.P. and M.H. are employees of SomaLogic. All other authors do not have any conflict of interest. TN has received speaking fees from Boehringer Ingelheim for talks unrelated to this research. S.G. reports other research funding from Bristol-Myers Squibb, Boehringer-Ingelheim, Celgene, Genentech, Regeneron, and Takeda. S.G. reports other research funding from Bristol-Myers Squibb, Boehringer-Ingelheim, Celgene, Genentech, Regeneron, and Takeda.